Newsroom

TORONTO--(BUSINESS WIRE)--Granite Real Estate Investment Trust (“Granite” or the “Trust”) (TSX: GRT.UN / NYSE: GRP.U) announced today that the last day of trading for Granite’s trust units ("Units") on the New York Stock Exchange ("NYSE") is expected to be December 31, 2025. Granite has filed an application for its Units to be quoted on the OTCQX platform, operated by OTC Markets Group Inc., and expects trading to begin on or about January 2, 2026. Unitholders will not be required to exchange t...

CHICAGO--(BUSINESS WIRE)--OFS Credit Company, Inc. (Nasdaq: OCCI) (“OFS Credit”, the “Company”, “we”, “us” or “our”), an investment company that primarily invests in collateralized loan obligation (“CLO”) equity and debt securities, today announced the following net asset value (“NAV”) estimate at November 30, 2025. Management’s unaudited estimate of the range of our NAV per share of our common stock at November 30, 2025 is between $5.01 and $5.11. This estimate is not a comprehensive statement...

DUBLIN--(BUSINESS WIRE)--The "Non-Opioid Therapeutics Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. This market research report focuses on the evolving landscape of the Non-Opioid Therapeutics Market. This sector has grown from USD 40.77 billion in 2024 to USD 43.78 billion in 2025, with projections suggesting a CAGR of 7.68% leading to a valuation of USD 73.72 billion by 2032. Non-opioid therapeutics have become critical in modern pain management, add...

WALTHAM, Mass.--(BUSINESS WIRE)--Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced that the U.S. Food and Drug Administration (FDA) has approved NUZOLVENCE® (zoliflodacin) for oral suspension, a first-in-class, single-dose oral medication for the treatment of uncomplicated urogenital gonorrhea in adults and pediatric patients 12 years and older weighing at least 35 kg. The development of NUZOLVENCE was part of a private, not-for-profit collaboration...

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to live better, today announced that it allocated a $2,802,125,000 tranche (the “Replacement Term Loans”) of new term B loans, the proceeds of which will be used to refinance all of its outstanding term B loans due 2031 (the “Third Amendment Term Loans”) and its outstanding term B loans due 2028 (the “First I...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced the closing of its previously announced exercise of certain outstanding warrants to purchase up to an aggregate of 426,390 shares originally issued in February 2025 and September 2025, having exercise prices of $36.00 and $10.98 per share, res...

OSAKA, Japan--(BUSINESS WIRE)--Capcom Co., Ltd. (TOKYO:9697) heeft vandaag aangekondigd dat de sciencefiction-actie-avonturengame PRAGMATA, een volledig nieuwe IP, op 24 april 2026 zal worden uitgebracht. PRAGMATA is een nieuw type sciencefiction-actie-avonturengame die puzzel- en actie-elementen combineert. In de game, die zich afspeelt op de maan in een nabije toekomst, werken de in een ruimtepak gehulde Hugh en het androïde meisje Diana samen terwijl ze vechten om terug te keren naar de aard...

WINNIPEG, Manitoba--(BUSINESS WIRE)--Ag Growth International Inc. (TSX: AFN) (“AGI”, the “Company”, “we” or “our”) is providing a default status report in accordance with the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”), in connection with its previously announced management cease trade order (“MCTO”). Further to AGI’s news release dated November 28, 2025 (the “MCTO News Release”), its principal regulator, the Manitoba Securi...

OSAKA, Japón--(BUSINESS WIRE)--Capcom Co., Ltd. (TOKYO:9697) ha anunciado hoy que PRAGMATA, un nuevo juego de acción y aventuras con temática de ciencia ficción, se lanzará el 24 de abril de 2026. PRAGMATA mezcla acción y puzles en un mundo futurista ambientado en la Luna. Los jugadores seguirán a Hugh, enfundado en su traje espacial, y a la androide Diana, mientras cooperan para regresar a la Tierra. El juego estará disponible en Nintendo Switch™ 2, además de PlayStation®5, Xbox Series X|S y P...

OSAKA, Giappone--(BUSINESS WIRE)--Capcom Co., Ltd. (TOKYO:9697) oggi ha annunciato che la pubblicazione del gioco di azione-avventura fantascientifico PRAGMATA, un IP totalmente nuovo, è prevista per il 24 aprile 2026. PRAGMATA è un nuovo tipo di gioco di azione-avventura fantascientifico che unisce elementi di puzzle e di azione. Nel gioco, ambientato sulla luna in un mondo del prossimo futuro, Hugh, vestito in tuta spaziale e Diana, la ragazza androide, collaborano mentre combattono per torna...